Virtual reality-based inhibition training influences food-related responses: no additional effects of repetitive transcranial magnetic stimulation - Scorecard - MDSpire
Advertisement
Virtual reality-based inhibition training influences food-related responses: no additional effects of repetitive transcranial magnetic stimulation
Clinical Scorecard: Effects of Virtual Reality Inhibition Training on Food-Related Responses: Assessing the Role of Repetitive Transcranial Magnetic Stimulation
At a Glance
Category
Detail
Condition
Maladaptive food craving and intake
Key Mechanisms
Cognitive inhibition training combined with rTMS targeting the DLPFC
Target Population
Healthy women with high trait food cravings and preference for high-calorie foods
Care Setting
Clinical research setting
Key Highlights
VR-based no-go training reduced positive implicit attitudes toward high-calorie foods.
Participants in the no-go group showed increased craving for low-calorie foods.
No-go training led to healthier food choices compared to the neutral group.
Effects were more pronounced in individuals with low-to-moderate baseline preferences for high-calorie foods.
No significant effects of rTMS were observed.
Guideline-Based Recommendations
Diagnosis
Assess implicit attitudes and food cravings before and after intervention.
Management
Implement VR-based no-go inhibition training for modulating food-related responses.
Monitoring & Follow-up
Evaluate changes in food choices and cravings post-intervention.
Risks
Consider individual differences in baseline food preferences when applying interventions.
Patient & Prescribing Data
Healthy women with high trait food cravings.
Combining cognitive training with brain stimulation may enhance intervention effectiveness.
Clinical Best Practices
Utilize VR environments to enhance engagement in cognitive interventions.
Incorporate implicit attitude assessments in food-related interventions.
Focus on individual differences in food preferences during treatment planning.
Tamoxifen is commonly prescribed in hormone receptor-positive breast cancer but also associated with weight gain, which can complicate survivorship care. This narrative review summarizes evidence on tamoxifen-associated weight gain and outlines pharmacologic weight management options in this population.
